Literature DB >> 16714455

Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response.

James M Provenzale1, Srinivasan Mukundan, Daniel P Barboriak.   

Abstract

Diffusion-weighted magnetic resonance (MR) imaging and perfusion MR imaging are advanced techniques that provide information not available from conventional MR imaging. In particular, these techniques have a number of applications with regard to characterization of tumors and assessment of tumor response to therapy. In this review, the authors describe the fundamental principles of diffusion-weighted and perfusion MR imaging and provide an overview of the ways in which these techniques are being used to characterize tumors by helping distinguish tumor types, assess tumor grade, and attempt to determine tumor margins. In addition, the role of these techniques for evaluating response to tumor therapy is outlined.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714455     DOI: 10.1148/radiol.2393042031

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  129 in total

1.  Stripe-like increase of rCBV beyond the visible border of glioblastomas: site of tumor infiltration growing after neurosurgery.

Authors:  Stella Blasel; Kea Franz; Hanns Ackermann; Stefan Weidauer; Friedhelm Zanella; Elke Hattingen
Journal:  J Neurooncol       Date:  2010-10-07       Impact factor: 4.130

2.  New similarity search based glioma grading.

Authors:  Katrin Haegler; Martin Wiesmann; Christian Böhm; Jessica Freiherr; Oliver Schnell; Hartmut Brückmann; Jörg-Christian Tonn; Jennifer Linn
Journal:  Neuroradiology       Date:  2011-12-14       Impact factor: 2.804

3.  Value and limitations of diffusion-weighted imaging in grading and diagnosis of pediatric posterior fossa tumors.

Authors:  J L Jaremko; L B O Jans; L T Coleman; M R Ditchfield
Journal:  AJNR Am J Neuroradiol       Date:  2010-06-10       Impact factor: 3.825

4.  Measurement of SUVmax plus ADCmin of the primary tumour is a predictor of prognosis in patients with cervical cancer.

Authors:  Keiichiro Nakamura; Ikuo Joja; Junichi Kodama; Atsushi Hongo; Yuji Hiramatsu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-11-10       Impact factor: 9.236

5.  Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma.

Authors:  Benjamin M Ellingson; Timothy F Cloughesy; Taryar Zaw; Albert Lai; Phioanh L Nghiemphu; Robert Harris; Shadi Lalezari; Naveed Wagle; Kourosh M Naeini; Jose Carrillo; Linda M Liau; Whitney B Pope
Journal:  Neuro Oncol       Date:  2012-01-22       Impact factor: 12.300

Review 6.  Texture analysis: a review of neurologic MR imaging applications.

Authors:  A Kassner; R E Thornhill
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-15       Impact factor: 3.825

7.  Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging.

Authors:  Won-Jin Moon; Jin Woo Choi; Hong Gee Roh; So Dug Lim; Young-Cho Koh
Journal:  Neuroradiology       Date:  2011-08-11       Impact factor: 2.804

8.  Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions.

Authors:  Sofia Gourtsoyianni; Nickolas Papanikolaou; Spyros Yarmenitis; Thomas Maris; Apostolos Karantanas; Nicholas Gourtsoyiannis
Journal:  Eur Radiol       Date:  2007-11-10       Impact factor: 5.315

Review 9.  Perfusion MRI: the five most frequently asked technical questions.

Authors:  Marco Essig; Mark S Shiroishi; Thanh Binh Nguyen; Marc Saake; James M Provenzale; David Enterline; Nicoletta Anzalone; Arnd Dörfler; Alex Rovira; Max Wintermark; Meng Law
Journal:  AJR Am J Roentgenol       Date:  2013-01       Impact factor: 3.959

10.  Intravoxel water diffusion heterogeneity imaging of human high-grade gliomas.

Authors:  Thomas C Kwee; Craig J Galbán; Christina Tsien; Larry Junck; Pia C Sundgren; Marko K Ivancevic; Timothy D Johnson; Charles R Meyer; Alnawaz Rehemtulla; Brian D Ross; Thomas L Chenevert
Journal:  NMR Biomed       Date:  2010-02       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.